Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 54 | Issue 3 | 2020 | pp. 698–704Open access
Nostocine A Derivatives as Human DNA Topoisomerase II-alpha Inhibitor
- 1,2,
- 2,
- 1*
- 1 Central Research Laboratory, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, INDIA.
- 2 Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Rabindra Nath Padhy
Central Research Laboratory, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, INDIA.
Email: rnpadhy54@gmail.com
Copyright: © 2020 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2020
- Received:
- Nov 16, 2019
- Accepted:
- Apr 14, 2020
- DOI:
- 10.5530/ijper.54.3.120
How to cite
Sahoo, C. R., Paidesetty, S. K., & Padhy, R. N. (2020). Nostocine A Derivatives as Human DNA Topoisomerase II-alpha Inhibitor. Indian Journal of Pharmaceutical Education and Research, 54(3), 698–704. https://doi.org/10.5530/ijper.54.3.120
Abstract
Introduction: Due to heavy morbidity and mortality from cancer, the designing of newer drugable molecules against breast cancer is the call of day. As, Schiff-base sulfonamides have been widely used in tumor treatments. Methods: Nostocine-sulfonamide (NS) Schiff-base molecules were designed with tools of bioinformatics against the target enzyme, human topoisomerase II-alpha (topo IIa) against breast cancer. The designed NS conjugates were assessed by RO5, ADMET and molecular docking. Results: Herein, these analogues, NS-20b (Nostocine A-sulfaphenazole), 12a (Nostocine A-sulfisoxazole) and 16b (Nostocine A-sulfamethazineare) are N-heteroaryl substituted sulfonamide moieties linked with pyrazolo[4,3-e][1,2,4]triazine of Nostocine A. Conclusion: These derivatives would act as potent inhibitors of topo IIa for breast cancer.
Keywords
Subject
Article metadata
| Title | Nostocine A Derivatives as Human DNA Topoisomerase II-alpha Inhibitor |
|---|---|
| Authors | Chita Ranjan Sahoo; Sudhir Kumar Paidesetty; Rabindra Nath Padhy |
| Affiliations | Central Research Laboratory, Institute of Medical Sciences and Sum Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, INDIA.; Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, INDIA. |
| Corresponding author | rnpadhy54@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 54, Issue 3 (2020) |
Also in this issue
- Is Covid-19 Sibling of SARS and MERS? A Review on: Novel Covid-19pp. 491–495
- Caspase Activators: Phytochemicals with Apoptotic Properties Targeting Cancer, a Health Care Strategy to Combat this Diseasepp. 496–508
- Therapeutic Potential of Chymase Inhibitors in Cardiovascular Diseases: An Overviewpp. 509–516
- Pharm D Program: Is it Necessary in BRICS?pp. 517–525
- Biomaterials in 3D Printing: A Special Emphasis on Nanocellulosepp. 526–540